GA

Gajanan Anandrao Masane

Active Director Director DIN 10442887
DIN 10442887 First appointment Dec 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Gajanan Anandrao Masane

Data last updated:

Gajanan Anandrao Masane is a Director at Yrish Healthcare Private Limited (since 2023). Yrish Healthcare Private Limited reported revenue of ₹69,271 (FY 2025).

DIN 10442887
Primary Designation Director
First Appointment 28 Dec 2023
Oldest Company Age 2 yrs
Largest company Yrish Healthcare Private Limited · ₹69,271 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yrish Healthcare Private Limited U86100MH2023PTC416167
Director28 Dec 20232023₹69,271 (FY 2025)Active

Board colleagues of Gajanan Anandrao Masane

Directorship timeline

Open interactive timeline →
Yrish Healthcare Private Limited
Premium access

Shareholding and investment profile for Gajanan Anandrao Masane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gajanan Anandrao Masane

Gajanan Anandrao Masane currently holds 1 directorship: Yrish Healthcare Private Limited (Director, since 28 Dec 2023, revenue ₹69,271 (FY 2025)).

Gajanan Anandrao Masane was first appointed on 28 Dec 2023 as Director at Yrish Healthcare Private Limited.

The current boards of Gajanan Anandrao Masane's companies include Archana Singh Patel (Yrish Healthcare Private Limited), Sudhanshu Gajanan Masane (Yrish Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available